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Purpose: To present anterior segment ophthalmic manifestations of WiskotteAldrich syndrome (WAS),
a rare X-linked primary immune-deﬁciency.
Observations: A 15-year old male with WAS presented with multiple corneal ulcers of the left eye. Once
resolved, this was followed by separate episodes of episcleritis in the left eye and corneal inﬁltrates of the
right eye. Successful treatment included topical antibiotics and anti-inﬂammatories.
Conclusions: Ocular manifestations of WAS, due to secondary infection and inﬂammation, may be se-
vere. This case report emphasizes the importance of prompt ophthalmic evaluation and treatment of
these patients.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
WiskotteAldrich syndrome (WAS) is an X-linked recessive pri-
mary immunodeﬁciency. This rare condition is characterized by an
increased risk of recurrent infection, thrombocytopenia and
eczema, which begins in infancy.1 Our case report involves a 15-
year-old male with WAS who presented initially with multiple
corneal ulcers followed by separate episodes of corneal inﬁltrates
and episcleritis.2. Case report
A 15-year-old Caucasian male presented with progressive
redness and pain of the left eye for 5 days. His pediatrician pre-
scribed moxiﬂoxacin ophthalmic solution and oral Augmentin one
day prior to presentation. Past ocular history was unremarkable.
Medical history was signiﬁcant for WAS. The patient was concur-
rently being managed by an otolaryngologist for chronic sinus in-
fections and undergoing iron infusion therapy for iron-deﬁciency
anemia.elbaum), Danielle.kalberer@
Pinchoff).
Inc. This is an open access article uUncorrected visual acuity was 20/25 in the right eye and 20/25
in the left. On slit lamp examination, mixed anterior and posterior
blepharitis was present in both eyes with mild ﬂaking on the pa-
tient's lashes. No telangectatic vessels were noted. The right cornea
showed a small inferior pannus with non-injected conjunctiva. The
conjunctiva of the left eye showed diffuse injection. The left cornea
displayed 5 areas of ulceration of which 3 were located superiorly
and 2 inferiorly (Fig. 1). All ulcers stained with ﬂuorescein. Both
anterior chambers were quiet. The patient was diagnosed with
corneal ulcers of the left eye, most likely due to an increased sus-
ceptibility and abnormal immune reaction to the common path-
ogen Staphylococcus aureus associated with chronic blepharitis.
Treatment consisted of continuing topical moxiﬂoxacin and oral
Augmentin as previously prescribed by the pediatrician. Topical
prednisolone acetate and ciproﬂoxacin ophthalmic ointment at
night were added. An extensive discussion took place with the
patient and his mother regarding lid hygiene practices. The
regimen to be used included warm compresses morning and night
with good lid hygiene.
At the follow-up visit, the corneal ulcers had decreased in size
with pinpoint staining along with quiet conjunctiva. Topical mox-
iﬂoxacin and prednisolone acetate were tapered and the cipro-
ﬂoxacin ointment was continued. At 1 week follow-up, the ulcers
were signiﬁcantly improved; however, peripheral corneal thinning
was evident. As the corneal thinning was attributed to the topicalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Two inferior corneal ulcerations (arrows).
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thinning recurred on follow-up exams.
Two months later, the patient presented with redness and
discomfort in the left eye of one days duration. The conjunctiva of
the left eye showed grade 2 sectoral injection temporally. Corneal
scars were present in the left eye with no staining. The right eye
remained quiet. The patient was diagnosed with episcleritis of the
left eye. Treatment consisted of prednisolone acetate ophthalmic
suspension twice a day; a lower dose due to the previous corneal
thinning noted. At follow-up 4 days later, the left eye's condition
had not improved and prednisolone acetatewas increased to 1 drop
four times daily. Subsequent follow-up showed that the condition
was markedly improved and the medication was tapered over the
course of two weeks with no recurrence.
One week after the episode of episcleritis resolved, the patient
presented with a painful red right eye of 2 days duration. Vision
remained unchanged. The conjunctiva of the right eye showed
diffuse injection more concentrated nasally. The right cornea dis-
played 2 areas of inﬁltration supero-nasally (Fig. 2). Slit lamp ex-
amination of the left eye was unremarkable. Both anterior
chambers were quiet. Treatment consisted of prednisolone acetate
ophthalmic suspension and moxiﬂoxacin solution both four timesFig. 2. Two supero-nasal corneal inﬁltrates (arrows).daily to the right eye. At follow-up 4 days later, the condition
showed only slight improvement and the patient was asked to
continue on the same medication course. At subsequent follow-up,
5 days later, the condition was markedly improved; the medica-
tions were tapered with no recurrence of the condition.
3. Discussion
WAS is a rare, X-linked primary immune deﬁciency due to
mutations of theWAS gene in hematopoietic cells.1 The classic triad
of eczema, thrombocytopenia and immunodeﬁciency is often
observed. The average incidence of WAS is approximately 4 cases
per million boys.2 Historically, patients suffering from this condi-
tion have a poor prognosis and survival beyond the second decade
is uncommon.3 Due to poor survival rate and rarity of the condition,
reports of WAS ophthalmic manifestations have been infrequent.
As treatments, including splenectomy, bone marrow trans-
plantation and gene therapy continue to improve prognosis, less
life-threatening complications have come to light.
Previously reported ophthalmic manifestations result from the
immune-compromised and the hemorrhagic state caused by WAS.
These include blepharoconjunctivitis, keratitis, corneal ulceration,
subconjunctival hemorrhage, and papilledema.4 Karampatakis
et al., in 2011 reported a case of scleritis and iritis in an 18-year old
Caucasian male with WAS.4 Guss et al., in 1982 presented three
cases with WAS-related episcleritis, marginal keratitis and chronic
blepharitis. One such case involved a 13-year oldmalewho suffered
from a single bacterial corneal ulcer adjacent to marginal keratitis.
The ulcer was cultured and the organism was identiﬁed as Hemo-
philus aeyptius, while a culture of the eyelids revealed various
strains of staphylococcus. According to Guss, WAS patients, who
commonly suffer from eczema, should be kept on a long-term lid
hygiene regimen, including vigorous lid scrubs, due to the
increased risk of bacterial infection and resultant blephar-
oconjunctivitis.4 Podos also attributed noted cases of conjunctivitis
and ulcerative keratitis to the presence of eczema of the eyelids.5
Podos, in 1969, noted that ophthalmic molluscum contagiosum
and herpes simplex infections were common in patients with WAS
in addition to or in conjunction with previously noted blephar-
oconjunctivitis. He also noted that the two most common bacterial
pathogens related to ocular manifestations were Staphyloccocus
and Hemophilus inﬂuenzae which is consistent with that reported
by Guss.5
Whereas previous, older cases used culturing to help manage
treatment modalities, we felt that with the advent of fourth gen-
eration ﬂuoroquinolones, culturing would not have changed our
initial management. Had the patient not responded to our initial
management, however, culturing would have been entertained.
4. Conclusion
Our patient had separate episodes of ocular manifestations
which included corneal ulceration, corneal inﬁltration and epis-
cleritis associated with WAS. Treatment with topical antibiotics,
and topical anti-inﬂammatories was successful in this case.
Chronic blepharitis and its sequelae are multifactorial in nature
and attributed to direct infection with staphylococcus, and in-
ﬂammatory or allergic reaction to exotoxin.6 While similar pre-
sentations can occur in immune-competent individuals, we believe
patients withWAS are at increased risk due to exaggeration of both
causative factors. We hypothesize that our patient's ocular mani-
festations were due to both increased propensity for infection due
to immune compromise and also abnormal responses to staphylo-
coccus aureus exotoxins, byproducts of the common eyelid
pathogen.
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disorders leading to WAS diagnosis, we must consider its role in
creating an altered ocular surface environment. Our patient did
have associated ocular signs including blepharitis with ﬂaking on
his lashes. In a study of keratoconjunctivitis associated with mei-
bomean gland dysfunction, those patients with underlying
dermatitis or atopic conditions showed the most severe ocular
signs.7
Whereas multiple proteins are secreted by staphylococcus
aureus, alpha-toxin has been identiﬁed as themost pathogenic. This
protein has known cytolytic properties and has been shown to
initiate the classical and alternate complement pathways, initiating
inﬂammatory reactions.8 The cyctolytic effect on the cornea can
lead to the creation of membrane-damaging pores, increasing ul-
ceration risk. The exotoxin increases incidence of inﬂammatory
response activation, which in the cornea involves inﬁltration of
white blood cells. In addition, episcleritis is caused by an inﬁltration
of mononuclear leukocytes from superﬁcial blood vessels.3
This report is one of few attestations to the need for ophthal-
mologic management of patients with WAS; this consists of erad-
ication of chronic infectious agents and management of chronic
inﬂammation.
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